Integrative molecular and clinical modeling of clinical outcomes to PD1 blockade in patients with metastatic melanoma von Liu, David, Schilling, Bastian, Liu, Derek, Sucker, Antje, Livingstone, Elisabeth, Jerby-Arnon, Livnat, Zimmer, Lisa, Gutzmer, Ralf, Satzger, Imke, Loquai, Carmen, Grabbe, Stephan, Vokes, Natalie, Margolis, Claire A., Conway, Jake, He, Meng Xiao, Elmarakeby, Haitham, Dietlein, Felix, Miao, Diana, Tracy, Adam, Gogas, Helen, Goldinger, Simone M., Utikal, Jochen, Blank, Christian U., Rauschenberg, Ricarda, von Bubnoff, Dagmar, Krackhardt, Angela, Weide, Benjamin, Haferkamp, Sebastian, Kiecker, Felix, Izar, Ben, Garraway, Levi, Regev, Aviv, Flaherty, Keith, Paschen, Annette, Van Allen, Eliezer M., Schadendorf, Dirk

Volltext

International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors von Panula, Pertti, Chazot, Paul L., Cowart, Marlon, Gutzmer, Ralf, Leurs, Rob, Liu, Wai L.S., Stark, Holger, Thurmond, Robin L., Haas, Helmut L.

Volltext

Genomic correlates of response to CTLA-4 blockade in metastatic melanoma von Van Allen, Eliezer M., Miao, Diana, Schilling, Bastian, Shukla, Sachet A., Blank, Christian, Zimmer, Lisa, Sucker, Antje, Hillen, Uwe, Foppen, Marnix H. Geukes, Goldinger, Simone M., Utikal, Jochen, Hassel, Jessica C., Weide, Benjamin, Kaehler, Katharina C., Loquai, Carmen, Mohr, Peter, Gutzmer, Ralf, Dummer, Reinhard, Gabriel, Stacey, Wu, Catherine J., Schadendorf, Dirk, Garraway, Levi A.

Volltext

Hedgehog Pathway Inhibition for the Treatment of Basal Cell Carcinoma von Gutzmer, Ralf, Solomon, James A.

Volltext

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial von Weber, Jeffrey S, Dr, D'Angelo, Sandra P, MD, Minor, David, MD, Hodi, F Stephen, MD, Gutzmer, Ralf, MD, Neyns, Bart, MD, Hoeller, Christoph, MD, Khushalani, Nikhil I, MD, Miller, Wilson H, MD, Lao, Christopher D, MD, Linette, Gerald P, MD, Thomas, Luc, MD, Lorigan, Paul, FRCP, Grossmann, Kenneth F, MD, Hassel, Jessica C, MD, Maio, Michele, MD, Sznol, Mario, MD, Ascierto, Paolo A, MD, Mohr, Peter, MD, Chmielowski, Bartosz, MD, Bryce, Alan, MD, Svane, Inge M, MD, Grob, Jean-Jacques, MD, Krackhardt, Angela M, MD, Horak, Christine, PhD, Lambert, Alexandre, PhD, Yang, Arvin S, MD, Larkin, James, FRCP

Volltext

The role of the histamine H4 receptor in atopic dermatitis and psoriasis von Schaper‐Gerhardt, Katrin, Rossbach, Kristine, Nikolouli, Eirini, Werfel, Thomas, Gutzmer, Ralf, Mommert, Susanne

Volltext

Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial von Ascierto, Paolo A, Dr, Del Vecchio, Michele, MD, Robert, Caroline, Prof, Mackiewicz, Andrzej, Prof, Chiarion-Sileni, Vanna, MD, Arance, Ana, MD, Lebbé, Céleste, Prof, Bastholt, Lars, MD, Hamid, Omid, MD, Rutkowski, Piotr, Prof, McNeil, Catriona, MD, Garbe, Claus, Prof, Loquai, Carmen, MD, Dreno, Brigitte, Prof, Thomas, Luc, Prof, Grob, Jean-Jacques, Prof, Liszkay, Gabriella, Prof, Nyakas, Marta, MD, Gutzmer, Ralf, Prof, Pikiel, Joanna, MD, Grange, Florent, MD, Hoeller, Christoph, MD, Ferraresi, Virginia, MD, Smylie, Michael, MD, Schadendorf, Dirk, Prof, Mortier, Laurent, Prof, Svane, Inge Marie, MD, Hennicken, Delphine, MSc, Qureshi, Anila, MD, Maio, Michele, MD

Volltext

Acquired IFNγ resistance impairs anti-tumor immunity and gives rise to T-cell-resistant melanoma lesions von Sucker, Antje, Zhao, Fang, Pieper, Natalia, Heeke, Christina, Maltaner, Raffaela, Stadtler, Nadine, Real, Birgit, Bielefeld, Nicola, Howe, Sebastian, Weide, Benjamin, Gutzmer, Ralf, Utikal, Jochen, Loquai, Carmen, Gogas, Helen, Klein-Hitpass, Ludger, Zeschnigk, Michael, Westendorf, Astrid M., Trilling, Mirko, Horn, Susanne, Schilling, Bastian, Schadendorf, Dirk, Griewank, Klaus G., Paschen, Annette

Volltext

Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial von Dummer, Reinhard, Prof, Schadendorf, Dirk, Prof, Ascierto, Paolo A, MD, Arance, Ana, MD, Dutriaux, Caroline, MD, Di Giacomo, Anna Maria, MD, Rutkowski, Piotr, Prof, Del Vecchio, Michele, MD, Gutzmer, Ralf, Prof, Mandala, Mario, MD, Thomas, Luc, Prof, Demidov, Lev, Prof, Garbe, Claus, Prof, Hogg, David, MD, Liszkay, Gabriella, Prof, Queirolo, Paola, MD, Wasserman, Ernesto, MD, Ford, James, MS, Weill, Marine, MSc, Sirulnik, L Andres, MD, Jehl, Valentine, MSc, Bozón, Viviana, MD, Long, Georgina V, Prof, Flaherty, Keith, MD

Volltext

Dabrafenib in BRAF -mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial von Hauschild, Axel, Prof, Grob, Jean-Jacques, Prof, Demidov, Lev V, Prof, Jouary, Thomas, MD, Gutzmer, Ralf, MD, Millward, Michael, MD, Rutkowski, Piotr, PhD, Blank, Christian U, PhD, Miller, Wilson H, PhD, Kaempgen, Eckhart, PhD, Martín-Algarra, Salvador, PhD, Karaszewska, Boguslawa, MD, Mauch, Cornelia, Prof, Chiarion-Sileni, Vanna, MD, Martin, Anne-Marie, PhD, Swann, Suzanne, PhD, Haney, Patricia, BSN, Mirakhur, Beloo, PhD, Guckert, Mary E, MSN, Goodman, Vicki, MD, Chapman, Paul B, MD

Volltext

The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma von Van Allen, Eliezer M, Wagle, Nikhil, Sucker, Antje, Treacy, Daniel J, Johannessen, Cory M, Goetz, Eva M, Place, Chelsea S, Taylor-Weiner, Amaro, Whittaker, Steven, Kryukov, Gregory V, Hodis, Eran, Rosenberg, Mara, McKenna, Aaron, Cibulskis, Kristian, Farlow, Deborah, Zimmer, Lisa, Hillen, Uwe, Gutzmer, Ralf, Goldinger, Simone M, Ugurel, Selma, Gogas, Helen J, Egberts, Friederike, Berking, Carola, Trefzer, Uwe, Loquai, Carmen, Weide, Benjamin, Hassel, Jessica C, Gabriel, Stacey B, Carter, Scott L, Getz, Gad, Garraway, Levi A, Schadendorf, Dirk

Volltext

Treatment with two different doses of sonidegib in patients with locally advanced or metastatic basal cell carcinoma (BOLT): a multicentre, randomised, double-blind phase 2 trial von Migden, Michael R, Dr, Guminski, Alexander, PhD, Gutzmer, Ralf, Prof, Dirix, Luc, MD, Lewis, Karl D, MD, Combemale, Patrick, MD, Herd, Robert M, MD, Kudchadkar, Ragini, MD, Trefzer, Uwe, Prof, Gogov, Sven, MD, Pallaud, Celine, PhD, Yi, Tingting, PhD, Mone, Manisha, PhD, Kaatz, Martin, MD, Loquai, Carmen, MD, Stratigos, Alexander J, Prof, Schulze, Hans-Joachim, MD, Plummer, Ruth, Prof, Chang, Anne Lynn S, MD, Cornélis, Frank, MD, Lear, John T, MD, Sellami, Dalila, MD, Dummer, Reinhard, Prof

Volltext

Anti-tumor effects of tirbanibulin in squamous cell carcinoma cells are mediated via disruption of tubulin-polymerization von DeTemple, Viola K., Walter, Antje, Bredemeier, Sabine, Gutzmer, Ralf, Schaper-Gerhardt, Katrin

Volltext

The histamine H4 receptor is functionally expressed on TH2 cells von GUTZMER, Ralf, MOMMERT, Susanne, GSCHWANDTNER, Maria, ZWINGMANN, Katja, STARK, Holger, WERFEL, Thomas

Volltext

Tolerability of BRAF/MEK inhibitor combinations: adverse event evaluation and management von Heinzerling, Lucie, Eigentler, Thomas K, Fluck, Michael, Hassel, Jessica C, Heller-Schenck, Daniela, Leipe, Jan, Pauschinger, Matthias, Vogel, Arndt, Zimmer, Lisa, Gutzmer, Ralf

Volltext

Assessment of various efficacy outcomes using ERIVANCE-like criteria in patients with locally advanced basal cell carcinoma receiving sonidegib: results from a preplanned sensitivi... von Gutzmer, Ralf, Robert, Caroline, Loquai, Carmen, Schadendorf, Dirk, Squittieri, Nicholas, Arntz, Ramon, Martelli, Serena, Dummer, Reinhard

Volltext

Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection von Gosmann, Janika, Stadler, Rudolf, Quint, Koen D., Gutzmer, Ralf, Vermeer, Maarten H.

Volltext

Human Memory Th17 Cells Express a Functional Histamine H4 Receptor von Mommert, Susanne, Gschwandtner, Maria, Koether, Brigitta, Gutzmer, Ralf, Werfel, Thomas

Volltext

Selumetinib plus dacarbazine versus placebo plus dacarbazine as first-line treatment for BRAF -mutant metastatic melanoma: a phase 2 double-blind randomised study von Robert, Caroline, Dr, Dummer, Reinhard, Prof, Gutzmer, Ralf, Prof, Lorigan, Paul, MB, Kim, Kevin B, MD, Nyakas, Marta, MD, Arance, Ana, MD, Liszkay, Gabriella, Prof, Schadendorf, Dirk, Prof, Cantarini, Mireille, MBChB, Spencer, Stuart, MSc, Middleton, Mark R, Prof

Volltext

Phase 2 study of cemiplimab in patients with metastatic cutaneous squamous cell carcinoma: primary analysis of fixed-dosing, long-term outcome of weight-based dosing von Rischin, Danny, Migden, Michael R, Lim, Annette M, Schmults, Chrysalyne D, Khushalani, Nikhil I, Hughes, Brett G M, Schadendorf, Dirk, Dunn, Lara A, Hernandez-Aya, Leonel, Chang, Anne Lynn S, Modi, Badri, Hauschild, Axel, Ulrich, Claas, Eigentler, Thomas, Stein, Brian, Pavlick, Anna C, Geiger, Jessica L, Gutzmer, Ralf, Alam, Murad, Okoye, Emmanuel, Mathias, Melissa, Jankovic, Vladimir, Stankevich, Elizabeth, Booth, Jocelyn, Li, Siyu, Lowy, Israel, Fury, Matthew G, Guminski, Alexander

Volltext